LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 125 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 3.94 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $461,000 | -16.3% | 82,915 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $551,000 | -68.9% | 82,915 | -50.0% | 0.00% | 0.0% |
| Q3 2018 | $1,770,000 | +76.3% | 165,830 | +98.2% | 0.00% | 0.0% |
| Q2 2018 | $1,004,000 | +51.7% | 83,674 | +8.4% | 0.00% | 0.0% |
| Q1 2018 | $662,000 | -13.2% | 77,189 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $763,000 | -19.6% | 77,189 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $949,000 | -25.3% | 77,189 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $1,270,000 | +24.5% | 77,189 | +8.5% | 0.00% | +100.0% |
| Q1 2017 | $1,020,000 | -31.0% | 71,112 | -33.5% | 0.00% | -50.0% |
| Q4 2016 | $1,478,000 | +2.9% | 106,890 | +34.4% | 0.00% | 0.0% |
| Q3 2016 | $1,437,000 | +47.7% | 79,512 | +17.3% | 0.00% | 0.0% |
| Q2 2016 | $973,000 | +35.7% | 67,782 | +12.9% | 0.00% | +100.0% |
| Q1 2016 | $717,000 | -10.3% | 60,041 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $799,000 | +23.9% | 60,041 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $645,000 | +33.5% | 60,041 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $483,000 | – | 60,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $37,033,000 | 100.00% |
| Artal Group S.A. | 58,274,650 | $499,413,000 | 6.25% |
| SECTOR GAMMA AS | 854,592 | $7,324,000 | 1.32% |
| NEA Management Company, LLC | 2,382,286 | $20,416,000 | 0.91% |
| Virtus ETF Advisers LLC | 89,845 | $770,000 | 0.67% |
| Malaga Cove Capital, LLC | 59,701 | $512,000 | 0.28% |
| MARSHALL WACE, LLP | 736,545 | $6,312,000 | 0.26% |
| USS Investment Management Ltd | 2,741,942 | $22,607,000 | 0.25% |
| CLEARBRIDGE, LLC | 1,172,117 | $10,045,000 | 0.22% |
| WEDBUSH SECURITIES INC | 155,396 | $1,332,000 | 0.17% |